Zebra Technologies Corp. announced the results of its Future of Healthcare: 2022 Hospital Vision Study, revealing the impact of mobile technology use in acute care hospitals. The research — which incorporates feedback from nursing managers, information technology (IT) decision-makers and patients — offers a perspective from the front-line of patient care. It also highlights the transformational power clinical mobility is expected to have on global health services within the next five years.

Researchers used machine learning techniques, including natural language processing algorithms, to identify clinical concepts in radiologist reports for computed tomography (CT) scans, according to a new study. The study was conducted at the Icahn School of Medicine at Mount Sinai and published in the journal Radiology. The technology is an important first step in the development of artificial intelligence (AI) that could interpret scans and diagnose conditions.

Elekta announced it is collaborating with IBM Watson Health to offer Watson for Oncology with Elekta’s cancer care solutions. Under the terms of a new agreement, Elekta will sell Watson for Oncology beginning in early 2018 as a clinical decision support (CDS) solution paired within Elekta’s digital cancer care solutions, including the Mosaiq oncology information system (OIS). Elekta intends to offer both solutions in most markets around the world including the U.S., Brazil, certain major European and Asian markets, as well as India and Australia.

Amazon, Berkshire Hathaway and JPMorgan Chase & Co. announced that they are partnering on ways to address healthcare for their U.S. employees, with the aim of improving employee satisfaction and reducing costs. The three companies, which bring their scale and complementary expertise to this long-term effort, will pursue this objective through an independent company that is free from profit-making incentives and constraints, according to the companies. The initial focus of the new company will be on technology solutions that will provide U.S. employees and their families with simplified, high-quality and transparent healthcare at a reasonable cost.

Imperial College Healthcare NHS Trust in London, U.K., has chosen RayStation as the sole treatment planning system for two sites in London: Charing Cross Hospital and Hammersmith Hospital. RayStation was selected following a thorough evaluation of all potential treatment planning systems on the market.